Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral rhLF in advanced renal cell carcinoma
NCT00095186Phase 2Completed
- Sponsor
- Agennix AG
- Start
- Sep 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of lactoferrin in renal cell carcinoma (RCC), sponsored by Agennix AG. Started Sep 2004; status: completed.
02
Drugs
lactoferrin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00095186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095186.